Bionano Genomics (BNGO) vs Regentis Biomaterials (RGNT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Bionano Genomics is the larger company by market cap ($16.9 million vs $11.2 million), about 1.5 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BNGO | RGNT |
|---|---|---|
| Share price | $1.44 | $1.60 |
| Market cap | $16.90M | $11.24M |
| 1-day change | -1.71% | -5.88% |
| YTD return | -6.21% | -76.26% |
| 1-year return | -32.63% | — |
| 5-year return | -99.95% | — |
| EPS (TTM) | $-2.98 | $-2.46 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $2.23 | $15.50 |
| 52-week low | $1.00 | $1.23 |
| Distance from 52-week high | -35.65% | -89.68% |
| Analyst consensus | none | none |
| Avg. price target upside | +248.43% | +525.00% |
| Average volume | 921.59K | 76.68K |
| Shares outstanding | 11.78M | 7.02M |
| Employees | 95 | — |
| Sector | Industrials | Health Care |
| Industry | Biotechnology: Laboratory Analytical Instruments | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- The two companies sit in different sectors: Bionano Genomics in Industrials and Regentis Biomaterials in Health Care.
About Bionano Genomics
BNGO stock →Bionano Genomics, Inc., together with its subsidiaries, provides genome analysis solutions in the Americas, Europe, the Middle East, Africa, China, Japan, South Korea, Singapore, India, and Australia. The company offers genome analysis software that enables genomics labs to analyze and interpret data across a range of platforms to generate informative data visualizations for streamlined and simple reporting of causal variants.
Industrials · Biotechnology: Laboratory Analytical Instruments · 95 employees
About Regentis Biomaterials
RGNT stock →Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee.
Health Care · Industrial Specialties
BNGO vs RGNT FAQ
Which is bigger, Bionano Genomics or Regentis Biomaterials?
Bionano Genomics (BNGO) is larger, with a market capitalization of $16.90M compared with $11.24M for Regentis Biomaterials (RGNT).
Are Bionano Genomics and Regentis Biomaterials in the same industry?
No. Bionano Genomics is in the Industrials sector, while Regentis Biomaterials is in Health Care.